Nathalie Belmonte
Chief Science & Technical Officer Quell Therapeutics
Seminars
Wednesday 2nd December 2026
Exploring Preclinical & Translational Strategies to Advance Autoimmune Cell Therapy Toward Clinical Readiness
3:30 pm
- Highlighting how emerging preclinical datasets and early PK insights can be leveraged to inform translational decision-making ahead of clinical readouts
- Addressing key challenges in bridging preclinical findings to human biology to improve confidence in safety and mechanism before entering later-stage trials
- Integrating translational learnings to guide clinical trial design strategy while managing expectations around early-stage data maturity
